The European Society of Cardiology (ESC) Congress was held in Munich this week and served as a platform for announcing the launch of various products and the results of exciting trials, particularly for medtech powerhouses such as Medtronic and St. Jude. Hot topics such as fractional flow reserve and renal denervation played a prominent role at the conference. Read more about some of the big news to come out of ESC in our weekly roundup below.

• Renal Denervation: All the Rage in Europe (MPMN)
• Clinical Trial Data Show Medtronic Symplicity Renal Denervation System Reduces Blood Pressure in All Treatment Groups (Qmed)
• Renal denervation technology from St. Jude Medical Demonstrates Safe, Rapid, and Sustained Reduction in Blood Pressure (Qmed)
• Renal Denervation Gets New Vote of Confidence in European Studies (MedCity News)
• Renal Denervation Improves Blood Pressure and Arterial Stiffness (EurekAlert)
• St. Jude's Fame II Trial Results Reveal Better Patient Outcomes with FFR-Guided Cardiac Stenting (Qmed)
• HeartFlow Announces Landmark Data Showing High Diagnostic Performance for Noninvasive Fractional Flow Reserve Technology (Qmed)